Solventum Corporation (SOLV)
SOLV stock forecast: what analysts expect
Wall Street analysts covering Solventum Corporation currently rate the stock a Buy on average, with a mean 12-month price target of $93.92 — +10.1% versus the last price of $85.29. Targets reflect analyst opinion, not a guarantee.
SOLV historical returns
Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in SOLV.
Congress trading in SOLV
2 members of Congress have disclosed trading SOLV — 0 purchases and 2 sales worth an estimated $40,500. Most recent disclosure: Dec 31, 2025.
About Solventum Corporation
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
SOLV Key Statistics
SOLV in plain English
- P/E ratio (10.3) — how many dollars you pay for each $1 of SOLV's yearly profit. That's on the low side, which can mean it's cheap — or that the market is worried.
- ROE (33.96%) — how efficiently the company turns shareholders' money into profit. Above ~20% is considered strong.
- Profit margin (17.26%) — of every $1 in sales, this is what's left as profit after all costs.
- Dividend — SOLV doesn't pay a meaningful dividend; the return here comes from the share price, not cash payouts.
SOLV stock: frequently asked questions
What is Solventum Corporation's stock price today?
Solventum Corporation (SOLV) last traded at $85.29 on the NYSE. Over the past 52 weeks the stock has traded between $62.38 and $90.00.
Is SOLV stock a buy or a sell?
Wall Street analysts' consensus rating on SOLV is "Buy", with an average 12-month price target of $93.92 — about +10.1% versus the current price of $85.29. Analyst targets are opinions, not guarantees; always do your own research.
Does SOLV pay a dividend?
No — Solventum Corporation does not currently pay a meaningful dividend. Returns for shareholders come from changes in the share price.
What is SOLV's P/E ratio?
SOLV trades at a trailing price-to-earnings ratio of 10.3, and 11.8 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.
Do members of Congress trade SOLV stock?
Yes — 2 members of Congress have disclosed trades in SOLV under the STOCK Act, totaling 0 purchases and 2 sales worth an estimated $40,500.
What is Solventum Corporation's ticker symbol?
Solventum Corporation trades under the ticker symbol SOLV on the NYSE.
Compare SOLV with peers
Data last refreshed from public sources. Figures may be delayed. Not investment advice.